top of page

We are the small private laboratory of biopharmaceutical research located in Slovakia.

​

Deciphering the bioactive profile of secondary metabolites from natural products and exploring therapeutic usefulness of various TLR agonists and combined approaches is at the core of our permanent research interests associated with in-house pharmaceutical development.

​

Our proprietary microbial biosynthesis platform suffices to modeling of various new and safe therapeutic strategies based on specific TLR2, -3, -4, -7/8, and -9 agonists.

Compound

Mechanism of action/Modality

Indication

Development stage

09092022

Ischemic preconditioning through low-dose modulation of TLR hyporeactivity.

Tolerance to hypoxia-ischaemia

Recurrent stroke secondary prevention (after TIA).

Neuroprotection, modulating neuroinflammation

09092022

Increasing hippocampal neurogenesis, antidepressant-like effects and reversal of stress-induced anhedonia, improving cognitive ability

Post-stroke recovery.

Slowing down or halting neurodegeneration, boosting adult neurogenesis for neurodegeneration-related cognitive decline.

Treatment of anhedonia and depressive disorders

VM71224

Regulator of tumor immune microenvironment.
Th1 cytotoxic responses induction

Cancer immunotherapy

Discovery

Preclinical

Preclinical

Helping others regain happiness

"For all people looking for a healthier and natural lifestyle, in search of sustainable solutions to maintain positive mental health and prevention of neurological disorders."

- Our value proposition
Terms of Use 
Privacy
Cookie Settings

© 2024 by VISSAN BioLabs

bottom of page